Download in electronic PDF format for $25



Search the Complete Journal Archives

PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Abstract:  

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, North American Menopause Society, bioidentical hormone replacement therapy, bHRT, unapproved drugs, U.S. Food and Drug Administration, FDA

Related Categories: HRT, LEGAL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T Nov/Dec 2001 462 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Allen Loyd V Jr Nov/Dec 2017 444 Buy
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr Jul/Aug 2007 350-351 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T Mar/Apr 2002 142 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Allen Loyd V Jr Sep/Oct 2007 438-439 Buy
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M May/Jun 2006 175-183 Buy